An study on the relationship between the change of echogenicity in substantia nigra by transcranial sonography and clinical features in patients with Parkinson's disease
CAO Chen-jie,YU Shu-yang,ZUO Li-jun,LI Chen,HU Yang,WANG Fang,CHEN Ze-jie,ZHANG Wei
DOI: https://doi.org/10.3969/cma.j.issn.1674-0785.2013.15.029
2013-01-01
Abstract:Objective To detect the echogenicity of substantia nigra(SN) by transcranial sonography(TCS) and investigate it's relationships with motor symptoms(MS) and non-motor symptoms(NMS) in patients with Parkinson's disease(PD). Methods(1)122 PD patients in Department of Neurology, Beijing Tiantan Hospital and 46 age and gender-matched healthy individuals were recruited from January 2012 to December 2012.(2) Echogenicity and hyperechogenicity area of SN and ratio of hyper-SN over ipsilateral midbrain(S/M) were detected by TCS; PD patients with echogenicity of gradeⅠ-Ⅱ and gradeⅢ-Ⅳ were included in PDSN- and PDSN+ groups, respectively.(3)MS was evaluated by Hoehn-Yahr Stage and Unified Parkinson's Disease Rating ScaleⅢ(UPDRS Ⅲ), and NMS was assessed by Non-motor Symptoms Questionnaire(NMSQ), Mini-Mental Status Examination(MMSE), Montreal Cognitive Assessment Scale(MoCA), Hamilton Anxiety Scale(HAMA), Hamilton Depression Scale(HAMD), Pittsburgh Sleep Quality Index Scale(PSQI), Epworth Sleepiness Scale(ESS), Scale For Outcomes in PD For Autonomic Symptoms(SCOPA-AUT), Fatigue Scale-14(FS-14) and Restless Legs Syndrome Severity Rating Scale(RLSRS).(4)The relationships between echogenicity of SN and MS and NMS were analyzed. Results(1) In 122 PD patients, there(was) were 0, 31, 57, 32 and 2 case(s) for grade Ⅰ-Ⅴof SN echogenicity,respectively,and 91 cases(74.6%)and 31 cases(25.4%)were in SN- and SN+ groups, respectively; In 40 cases normal subjects(6 cases were not detected due to poor temporal window condition), there(was) were 11, 26, 3, 0 and 0 case(s) for gradeⅠ-Ⅴof SN echogenicity,respectively,and 3 cases(7.5%)and 31case(92.5%)were in SN+and SN- groups, respectively; the incidence of SN hyperechogenicity in PD group was significantly higher than that in control group(P<0.05); The hyperechogenicity area of SN and S/M ratio in PD patients with different grade of echogenicity were all significantly higher than that in control group(P< 0.05).(2)The incidence of PDSN(+) in male was significantly higher than that of female(P<0.05). The age and age onset of PDSN+group were notably older than that of PDSN- group,(62.0±9.6) years vs.(54.3±11.1)years,(57.9 ±11.0) years vs.(51.1±10.9)years, P<0.05.(3) H-Y stage in PDSN+group was prominently severe compare with PDSN- group,(2.06±0.77)stage vs.(1.68±0.63)stage, P<0.05, and tremor score of UPDRSⅢ in PDSN+ group was significantly higher than that in PDSN- group(P<0.05); Onset side in 72 out of 92 cases(79.1%)in PDSN + group was in the opposite side of SN hyperechogenicity or the side with larger area of SN hyperechogenicity if both sides involved, 19 cases(20.9%)was in the same side with SN hyperechogenicity or the side with larger area of SN hyperechogenicity if both sides involved.(4)MoCA score in PDSN+group was significantly declined compared with SN- group,(20.1±5.4) points vs.(22.7±5.8)points,P<0.05, the incidences of PD with mild cognitive impairment in PDSN+group were remarkably higher than that in PDSN+ group,63.74% vs. 32.26%, P<0.05; SCOPA-AUT score in PDSN+group was significantly higher than that in PDSN- group,(36.8±9.0) points vs.(33.5±7.7)points, P<0.05; The incidences and scores of other NMS in two groups were not different(P>0.05). Conclusions PD patients have high incidences of SN hyperechogenicity detected by TCS. Echogenicity, hyperechogenicity area of SN and S/M ration all reflect SN echogenicity; factors relating higher incidences of SN hyperechogenicity in PD patients include male, older age and older onset age; PD patients present the onset symptoms in the opposite side of SN hyperechogenicity, show a higher H-Y stage, severer tremor and significantly impaired cognitive and autonomic functions.